The global market for Classical Swine Fever Live Vaccine was estimated to be worth US$ 154.7 million in 2023 and is forecast to a readjusted size of US$ 210.9 million by 2030 with a CAGR of 4.6% during the forecast period 2024-2030

Classical Swine Fever Live Vaccine - Market

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

The Classical Swine Fever Live Vaccine market is primarily driven by the need to control and prevent the spread of the highly contagious and economically devastating hog cholera virus (classical swine fever). Vaccination plays a critical role in protecting swine populations and the pig farming industry from this deadly viral disease, which can result in high mortality rates and trade restrictions. The global demand for pork products also fuels the need to ensure the health and well-being of swine herds, making the hog cholera vaccine essential in maintaining a stable and profitable pork supply chain. However, the market also faces challenges, such as the emergence of new strains of the hog cholera virus, which may require the development of updated or novel vaccine formulations. Ensuring the efficacy and safety of vaccines against these evolving strains is crucial to maintain disease control measures. Additionally, the cost of vaccination programs and the accessibility of vaccines to pig farmers, especially in developing regions, can pose obstacles to widespread adoption. Addressing these challenges through continued research and development, international cooperation in disease monitoring, and government support in implementing effective vaccination programs will be essential to drive the growth of the hog cholera vaccine market and protect the swine industry from this significant threat.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Classical Swine Fever Live Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Classical Swine Fever Live Vaccine by region & country, by Type, and by Application.

The Classical Swine Fever Live Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Classical Swine Fever Live Vaccine.

Market Segmentation

Scope of Classical Swine Fever Live Vaccine - Market Report

Report Metric	Details
Report Name	Classical Swine Fever Live Vaccine - Market
Forecasted market size in 2030	US$ 210.9 million
CAGR	4.6%
Forecasted years	2024 - 2030
Segment by Type:	Tissue Culture Origin Cell Line Origin
Segment by Application	Market Sales Government Tender
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WINSUN, Boehringer Ingelheim, CAHIC, SPAH, Merck, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory, Ringpu Biology, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, Tecon
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Classical Swine Fever Live Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Classical Swine Fever Live Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Classical Swine Fever Live Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Classical Swine Fever Live Vaccine - Market size in 2030?

Ans: The Classical Swine Fever Live Vaccine - Market size in 2030 will be US$ 210.9 million.

Who are the main players in the Classical Swine Fever Live Vaccine - Market report?

Ans: The main players in the Classical Swine Fever Live Vaccine - Market are WINSUN, Boehringer Ingelheim, CAHIC, SPAH, Merck, Ceva, Harbin Veterinary Research Institute, Qilu Animal Health Products Factory, Ringpu Biology, DHN, CAVAC, Komipharm, Agrovet, Bioveta, Jinyu Bio-Technology, Institutul Pasteur, MVP, Tecon

What are the Application segmentation covered in the Classical Swine Fever Live Vaccine - Market report?

Ans: The Applications covered in the Classical Swine Fever Live Vaccine - Market report are Market Sales, Government Tender

What are the Type segmentation covered in the Classical Swine Fever Live Vaccine - Market report?

Ans: The Types covered in the Classical Swine Fever Live Vaccine - Market report are Tissue Culture Origin, Cell Line Origin

1 Market Overview

1.1 Classical Swine Fever Live Vaccine Product Introduction

1.2 Global Classical Swine Fever Live Vaccine Market Size Forecast

1.2.1 Global Classical Swine Fever Live Vaccine Sales Value (2019-2030)

1.2.2 Global Classical Swine Fever Live Vaccine Sales Volume (2019-2030)

1.2.3 Global Classical Swine Fever Live Vaccine Sales Price (2019-2030)

1.3 Classical Swine Fever Live Vaccine Market Trends & Drivers

1.3.1 Classical Swine Fever Live Vaccine Industry Trends

1.3.2 Classical Swine Fever Live Vaccine Market Drivers & Opportunity

1.3.3 Classical Swine Fever Live Vaccine Market Challenges

1.3.4 Classical Swine Fever Live Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Classical Swine Fever Live Vaccine Players Revenue Ranking (2023)

2.2 Global Classical Swine Fever Live Vaccine Revenue by Company (2019-2024)

2.3 Global Classical Swine Fever Live Vaccine Players Sales Volume Ranking (2023)

2.4 Global Classical Swine Fever Live Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Classical Swine Fever Live Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Classical Swine Fever Live Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Classical Swine Fever Live Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Classical Swine Fever Live Vaccine

2.9 Classical Swine Fever Live Vaccine Market Competitive Analysis

2.9.1 Classical Swine Fever Live Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Classical Swine Fever Live Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Classical Swine Fever Live Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Tissue Culture Origin

3.1.2 Cell Line Origin

3.2 Global Classical Swine Fever Live Vaccine Sales Value by Type

3.2.1 Global Classical Swine Fever Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Classical Swine Fever Live Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Classical Swine Fever Live Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Classical Swine Fever Live Vaccine Sales Volume by Type

3.3.1 Global Classical Swine Fever Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Classical Swine Fever Live Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Classical Swine Fever Live Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Classical Swine Fever Live Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Market Sales

4.1.2 Government Tender

4.2 Global Classical Swine Fever Live Vaccine Sales Value by Application

4.2.1 Global Classical Swine Fever Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Classical Swine Fever Live Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Classical Swine Fever Live Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Classical Swine Fever Live Vaccine Sales Volume by Application

4.3.1 Global Classical Swine Fever Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Classical Swine Fever Live Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Classical Swine Fever Live Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Classical Swine Fever Live Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Classical Swine Fever Live Vaccine Sales Value by Region

5.1.1 Global Classical Swine Fever Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Classical Swine Fever Live Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Classical Swine Fever Live Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Classical Swine Fever Live Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Classical Swine Fever Live Vaccine Sales Volume by Region

5.2.1 Global Classical Swine Fever Live Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Classical Swine Fever Live Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Classical Swine Fever Live Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Classical Swine Fever Live Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Classical Swine Fever Live Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Classical Swine Fever Live Vaccine Sales Value, 2019-2030

5.4.2 North America Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Classical Swine Fever Live Vaccine Sales Value, 2019-2030

5.5.2 Europe Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Classical Swine Fever Live Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Classical Swine Fever Live Vaccine Sales Value, 2019-2030

5.7.2 South America Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Classical Swine Fever Live Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value

6.2.1 Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Classical Swine Fever Live Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.3.2 United States Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.4.2 Europe Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.5.2 China Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.6.2 Japan Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.7.2 South Korea Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Classical Swine Fever Live Vaccine Sales Value, 2019-2030

6.9.2 India Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Classical Swine Fever Live Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 WINSUN

7.1.1 WINSUN Company Information

7.1.2 WINSUN Introduction and Business Overview

7.1.3 WINSUN Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 WINSUN Classical Swine Fever Live Vaccine Product Offerings

7.1.5 WINSUN Recent Development

7.2 Boehringer Ingelheim

7.2.1 Boehringer Ingelheim Company Information

7.2.2 Boehringer Ingelheim Introduction and Business Overview

7.2.3 Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Boehringer Ingelheim Classical Swine Fever Live Vaccine Product Offerings

7.2.5 Boehringer Ingelheim Recent Development

7.3 CAHIC

7.3.1 CAHIC Company Information

7.3.2 CAHIC Introduction and Business Overview

7.3.3 CAHIC Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 CAHIC Classical Swine Fever Live Vaccine Product Offerings

7.3.5 CAHIC Recent Development

7.4 SPAH

7.4.1 SPAH Company Information

7.4.2 SPAH Introduction and Business Overview

7.4.3 SPAH Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 SPAH Classical Swine Fever Live Vaccine Product Offerings

7.4.5 SPAH Recent Development

7.5 Merck

7.5.1 Merck Company Information

7.5.2 Merck Introduction and Business Overview

7.5.3 Merck Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Merck Classical Swine Fever Live Vaccine Product Offerings

7.5.5 Merck Recent Development

7.6 Ceva

7.6.1 Ceva Company Information

7.6.2 Ceva Introduction and Business Overview

7.6.3 Ceva Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Ceva Classical Swine Fever Live Vaccine Product Offerings

7.6.5 Ceva Recent Development

7.7 Harbin Veterinary Research Institute

7.7.1 Harbin Veterinary Research Institute Company Information

7.7.2 Harbin Veterinary Research Institute Introduction and Business Overview

7.7.3 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product Offerings

7.7.5 Harbin Veterinary Research Institute Recent Development

7.8 Qilu Animal Health Products Factory

7.8.1 Qilu Animal Health Products Factory Company Information

7.8.2 Qilu Animal Health Products Factory Introduction and Business Overview

7.8.3 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product Offerings

7.8.5 Qilu Animal Health Products Factory Recent Development

7.9 Ringpu Biology

7.9.1 Ringpu Biology Company Information

7.9.2 Ringpu Biology Introduction and Business Overview

7.9.3 Ringpu Biology Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Ringpu Biology Classical Swine Fever Live Vaccine Product Offerings

7.9.5 Ringpu Biology Recent Development

7.10 DHN

7.10.1 DHN Company Information

7.10.2 DHN Introduction and Business Overview

7.10.3 DHN Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 DHN Classical Swine Fever Live Vaccine Product Offerings

7.10.5 DHN Recent Development

7.11 CAVAC

7.11.1 CAVAC Company Information

7.11.2 CAVAC Introduction and Business Overview

7.11.3 CAVAC Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 CAVAC Classical Swine Fever Live Vaccine Product Offerings

7.11.5 CAVAC Recent Development

7.12 Komipharm

7.12.1 Komipharm Company Information

7.12.2 Komipharm Introduction and Business Overview

7.12.3 Komipharm Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Komipharm Classical Swine Fever Live Vaccine Product Offerings

7.12.5 Komipharm Recent Development

7.13 Agrovet

7.13.1 Agrovet Company Information

7.13.2 Agrovet Introduction and Business Overview

7.13.3 Agrovet Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Agrovet Classical Swine Fever Live Vaccine Product Offerings

7.13.5 Agrovet Recent Development

7.14 Bioveta

7.14.1 Bioveta Company Information

7.14.2 Bioveta Introduction and Business Overview

7.14.3 Bioveta Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Bioveta Classical Swine Fever Live Vaccine Product Offerings

7.14.5 Bioveta Recent Development

7.15 Jinyu Bio-Technology

7.15.1 Jinyu Bio-Technology Company Information

7.15.2 Jinyu Bio-Technology Introduction and Business Overview

7.15.3 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.15.4 Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product Offerings

7.15.5 Jinyu Bio-Technology Recent Development

7.16 Institutul Pasteur

7.16.1 Institutul Pasteur Company Information

7.16.2 Institutul Pasteur Introduction and Business Overview

7.16.3 Institutul Pasteur Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.16.4 Institutul Pasteur Classical Swine Fever Live Vaccine Product Offerings

7.16.5 Institutul Pasteur Recent Development

7.17 MVP

7.17.1 MVP Company Information

7.17.2 MVP Introduction and Business Overview

7.17.3 MVP Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.17.4 MVP Classical Swine Fever Live Vaccine Product Offerings

7.17.5 MVP Recent Development

7.18 Tecon

7.18.1 Tecon Company Information

7.18.2 Tecon Introduction and Business Overview

7.18.3 Tecon Classical Swine Fever Live Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.18.4 Tecon Classical Swine Fever Live Vaccine Product Offerings

7.18.5 Tecon Recent Development

8 Industry Chain Analysis

8.1 Classical Swine Fever Live Vaccine Industrial Chain

8.2 Classical Swine Fever Live Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Classical Swine Fever Live Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Classical Swine Fever Live Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Harbin Veterinary Research Institute

Qilu Animal Health Products Factory

List of Tables

Table 1. Classical Swine Fever Live Vaccine Market Trends

Table 2. Classical Swine Fever Live Vaccine Market Drivers & Opportunity

Table 3. Classical Swine Fever Live Vaccine Market Challenges

Table 4. Classical Swine Fever Live Vaccine Market Restraints

Table 5. Global Classical Swine Fever Live Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Classical Swine Fever Live Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Classical Swine Fever Live Vaccine Sales Volume by Company (2019-2024) & (M Units)

Table 8. Global Classical Swine Fever Live Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Classical Swine Fever Live Vaccine Price by Company (2019-2024) & (US$/K Unit)

Table 10. Key Manufacturers Classical Swine Fever Live Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Classical Swine Fever Live Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Classical Swine Fever Live Vaccine

Table 13. Global Classical Swine Fever Live Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Classical Swine Fever Live Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Classical Swine Fever Live Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Classical Swine Fever Live Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Classical Swine Fever Live Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Classical Swine Fever Live Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Classical Swine Fever Live Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Classical Swine Fever Live Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)

Table 22. Global Classical Swine Fever Live Vaccine Sales Volume by Type (2019-2024) & (M Units)

Table 23. Global Classical Swine Fever Live Vaccine Sales Volume by Type (2025-2030) & (M Units)

Table 24. Global Classical Swine Fever Live Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Classical Swine Fever Live Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Classical Swine Fever Live Vaccine Price by Type (2019-2024) & (US$/K Unit)

Table 27. Global Classical Swine Fever Live Vaccine Price by Type (2025-2030) & (US$/K Unit)

Table 28. Global Classical Swine Fever Live Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Classical Swine Fever Live Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Classical Swine Fever Live Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Classical Swine Fever Live Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Classical Swine Fever Live Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Classical Swine Fever Live Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)

Table 34. Global Classical Swine Fever Live Vaccine Sales Volume by Application (2019-2024) & (M Units)

Table 35. Global Classical Swine Fever Live Vaccine Sales Volume by Application (2025-2030) & (M Units)

Table 36. Global Classical Swine Fever Live Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Classical Swine Fever Live Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Classical Swine Fever Live Vaccine Price by Application (2019-2024) & (US$/K Unit)

Table 39. Global Classical Swine Fever Live Vaccine Price by Application (2025-2030) & (US$/K Unit)

Table 40. Global Classical Swine Fever Live Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Classical Swine Fever Live Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Classical Swine Fever Live Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Classical Swine Fever Live Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Classical Swine Fever Live Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Classical Swine Fever Live Vaccine Sales Volume by Region (M Units): 2019 VS 2023 VS 2030

Table 46. Global Classical Swine Fever Live Vaccine Sales Volume by Region (2019-2024) & (M Units)

Table 47. Global Classical Swine Fever Live Vaccine Sales Volume by Region (2025-2030) & (M Units)

Table 48. Global Classical Swine Fever Live Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Classical Swine Fever Live Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Classical Swine Fever Live Vaccine Average Price by Region (2019-2024) & (US$/K Unit)

Table 51. Global Classical Swine Fever Live Vaccine Average Price by Region (2025-2030) & (US$/K Unit)

Table 52. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Volume, (2019-2024) & (M Units)

Table 56. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Volume, (2025-2030) & (M Units)

Table 57. WINSUN Company Information

Table 58. WINSUN Introduction and Business Overview

Table 59. WINSUN Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 60. WINSUN Classical Swine Fever Live Vaccine Product Offerings

Table 61. WINSUN Recent Development

Table 62. Boehringer Ingelheim Company Information

Table 63. Boehringer Ingelheim Introduction and Business Overview

Table 64. Boehringer Ingelheim Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 65. Boehringer Ingelheim Classical Swine Fever Live Vaccine Product Offerings

Table 66. Boehringer Ingelheim Recent Development

Table 67. CAHIC Company Information

Table 68. CAHIC Introduction and Business Overview

Table 69. CAHIC Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 70. CAHIC Classical Swine Fever Live Vaccine Product Offerings

Table 71. CAHIC Recent Development

Table 72. SPAH Company Information

Table 73. SPAH Introduction and Business Overview

Table 74. SPAH Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 75. SPAH Classical Swine Fever Live Vaccine Product Offerings

Table 76. SPAH Recent Development

Table 77. Merck Company Information

Table 78. Merck Introduction and Business Overview

Table 79. Merck Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 80. Merck Classical Swine Fever Live Vaccine Product Offerings

Table 81. Merck Recent Development

Table 82. Ceva Company Information

Table 83. Ceva Introduction and Business Overview

Table 84. Ceva Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 85. Ceva Classical Swine Fever Live Vaccine Product Offerings

Table 86. Ceva Recent Development

Table 87. Harbin Veterinary Research Institute Company Information

Table 88. Harbin Veterinary Research Institute Introduction and Business Overview

Table 89. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 90. Harbin Veterinary Research Institute Classical Swine Fever Live Vaccine Product Offerings

Table 91. Harbin Veterinary Research Institute Recent Development

Table 92. Qilu Animal Health Products Factory Company Information

Table 93. Qilu Animal Health Products Factory Introduction and Business Overview

Table 94. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 95. Qilu Animal Health Products Factory Classical Swine Fever Live Vaccine Product Offerings

Table 96. Qilu Animal Health Products Factory Recent Development

Table 97. Ringpu Biology Company Information

Table 98. Ringpu Biology Introduction and Business Overview

Table 99. Ringpu Biology Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 100. Ringpu Biology Classical Swine Fever Live Vaccine Product Offerings

Table 101. Ringpu Biology Recent Development

Table 102. DHN Company Information

Table 103. DHN Introduction and Business Overview

Table 104. DHN Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 105. DHN Classical Swine Fever Live Vaccine Product Offerings

Table 106. DHN Recent Development

Table 107. CAVAC Company Information

Table 108. CAVAC Introduction and Business Overview

Table 109. CAVAC Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 110. CAVAC Classical Swine Fever Live Vaccine Product Offerings

Table 111. CAVAC Recent Development

Table 112. Komipharm Company Information

Table 113. Komipharm Introduction and Business Overview

Table 114. Komipharm Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 115. Komipharm Classical Swine Fever Live Vaccine Product Offerings

Table 116. Komipharm Recent Development

Table 117. Agrovet Company Information

Table 118. Agrovet Introduction and Business Overview

Table 119. Agrovet Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 120. Agrovet Classical Swine Fever Live Vaccine Product Offerings

Table 121. Agrovet Recent Development

Table 122. Bioveta Company Information

Table 123. Bioveta Introduction and Business Overview

Table 124. Bioveta Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 125. Bioveta Classical Swine Fever Live Vaccine Product Offerings

Table 126. Bioveta Recent Development

Table 127. Jinyu Bio-Technology Company Information

Table 128. Jinyu Bio-Technology Introduction and Business Overview

Table 129. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 130. Jinyu Bio-Technology Classical Swine Fever Live Vaccine Product Offerings

Table 131. Jinyu Bio-Technology Recent Development

Table 132. Institutul Pasteur Company Information

Table 133. Institutul Pasteur Introduction and Business Overview

Table 134. Institutul Pasteur Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 135. Institutul Pasteur Classical Swine Fever Live Vaccine Product Offerings

Table 136. Institutul Pasteur Recent Development

Table 137. MVP Company Information

Table 138. MVP Introduction and Business Overview

Table 139. MVP Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 140. MVP Classical Swine Fever Live Vaccine Product Offerings

Table 141. MVP Recent Development

Table 142. Tecon Company Information

Table 143. Tecon Introduction and Business Overview

Table 144. Tecon Classical Swine Fever Live Vaccine Sales (M Units), Revenue (US$ Million), Price (US$/K Unit) and Gross Margin (2019-2024)

Table 145. Tecon Classical Swine Fever Live Vaccine Product Offerings

Table 146. Tecon Recent Development

Table 147. Key Raw Materials Lists

Table 148. Raw Materials Key Suppliers Lists

Table 149. Classical Swine Fever Live Vaccine Downstream Customers

Table 150. Classical Swine Fever Live Vaccine Distributors List

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

List of Figures

Figure 1. Classical Swine Fever Live Vaccine Product Picture

Figure 2. Global Classical Swine Fever Live Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Classical Swine Fever Live Vaccine Sales Volume (2019-2030) & (M Units)

Figure 5. Global Classical Swine Fever Live Vaccine Sales Price (2019-2030) & (US$/K Unit)

Figure 6. Classical Swine Fever Live Vaccine Report Years Considered

Figure 7. Global Classical Swine Fever Live Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Classical Swine Fever Live Vaccine Players Sales Volume Ranking (2023) & (M Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Classical Swine Fever Live Vaccine Revenue in 2023

Figure 10. Classical Swine Fever Live Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Tissue Culture Origin Picture

Figure 12. Cell Line Origin Picture

Figure 13. Global Classical Swine Fever Live Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Classical Swine Fever Live Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Classical Swine Fever Live Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)

Figure 16. Global Classical Swine Fever Live Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Classical Swine Fever Live Vaccine Price by Type (2019-2030) & (US$/K Unit)

Figure 18. Product Picture of Market Sales

Figure 19. Product Picture of Government Tender

Figure 20. Global Classical Swine Fever Live Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Classical Swine Fever Live Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Classical Swine Fever Live Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)

Figure 23. Global Classical Swine Fever Live Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Classical Swine Fever Live Vaccine Price by Application (2019-2030) & (US$/K Unit)

Figure 25. North America Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Classical Swine Fever Live Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Classical Swine Fever Live Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Classical Swine Fever Live Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Classical Swine Fever Live Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Classical Swine Fever Live Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Classical Swine Fever Live Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Classical Swine Fever Live Vaccine Industrial Chain

Figure 59. Classical Swine Fever Live Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions